Pharmaceutical manufacturers face growing pressure to move beyond isolated automation islands. They need fully connected, plant-wide systems instead. Biophorum’s Digital Plant Maturity Model makes it clear: Level 3, the connected plant, is now table stakes to compete. yet many companies still struggle to make the leap. Data stays fragmented across systems. Operator interfaces vary wildly.…
Eli Lilly to build new $6B API manufacturing facility in Alabama
Eli Lilly (NYSE:LLY) announced that it plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ingredient (API) facility marks the third of four new U.S. sites. It follows the new facilities announced in Virginia and Texas. Eli Lilly plans for the plant to produce small-molecule…
Coriolis meter options for pharmaceutical applications
Small form factor hygienic sensors, along with fit for purpose full-featured transmitters, provide increased value for the life sciences Industry. Coriolis flow meters have long played a vital role in pharmaceutical applications. Biotech processes often involve high value materials and highly sensitive operations, making consistent and accurate mass flow measurement essential for maintaining tight control…
Cardinal Health to build pharma distribution plant in Indianapolis
Cardinal Health (NYSE:CAH) today announced plans for a new flagship forward distribution center in Indianapolis. The new, state-of-the-art facility will further expand and modernize its national pharmaceutical distribution network. Dublin, Ohio-based Cardinal Health plans to include automation and the latest technology advancements in the new plant. It hopes to support the segment’s distribution of more…
Optel acquires Vanguard Robotics to automate pharma production
Optel Group announced that it acquired Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. The acquisition reinforces Optel’s commitment to pharmaceutical automation as a leader in traceability and supply chain solutions. By integrating Vanguard’s robotics technology, Optel believes it can help pharmaceutical manufacturers address labor constraints. It also expects the deal to enhance…
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Nymi today announced a strategic partnership with Caliber Technologies to accelerate digital transformation in pharmaceutical manufacturing. The partnership aims to enable passwordless authentication on the shop floor. This reduces manual logins and streamlines electronic signatures. Nymi offers the Band biometric, wearable device that authenticates users via fingerprint and facilitates a secure, continuous identity across applications,…
Moving toward the autonomous lab and what’s possible today
It comes as no surprise that automation and contextualized data are popular topics of conversation in life sciences today. After all, automation drives repeatability, repeatability drives speed and safety, and increased speed and safety means getting critical treatments into the hands of patients as fast as possible. In fact, one could imagine a result of…
Sherwin-Williams expands flooring solutions for pharma facilities
Sherwin-Williams High-Performance Flooring announced the launch of Accelera One, a grout and topcoat technology for pharmaceutical manufacturing environments. The technology offers benefits for pharmaceutical, life sciences, R&D and biopharma manufacturing spaces. A next-generation, ultra-high solids coating formulated to minimize downtime, it can also enhance durability and support green building goals. Accelera One delivers rapid cure…
Purdue, Eli Lilly, Merck form new pharma manufacturing consortium
Purdue University, Eli Lilly and Co., and Merck & Co. have launched the Young Institute Pharmaceutical Manufacturing Consortium, a collaborative effort to pioneer advances in making medicines. Operating within Purdue’s William D. and Sherry L. Young Institute for Advanced Manufacturing of Pharmaceuticals, consortium partners will focus on advancing pharmaceutical manufacturing, according to a Jan. 17 news…
CellProthera inks deal for GMP cell therapy manufacturing
CellProthera announced a deal with Shonan Kamakura General Hospital (SKGH) to transfer technology to enable cell therapy manufacturing for clinical trials. The memorandum of understanding allows for GMP manufacturing of CD34+ endothelial progenitor cells (EPCs) for autologous therapy clinical trials. Takayuki Asahara of SKGH intends to adopt CellProthera’s StemXpand platform for clinical trials starting next…